Michael N. Abrams

Opinion author

Michael Abrams is co-founder and managing partner of Numerof & Associates, a leading strategy and implementation consultancy that provides customized strategy and operational solutions to organizations across the healthcare industry. Working globally with manufacturers, payers and delivery, Numerof specializes in evaluating the viability of product pipelines, redesigning medical and commercial models, crafting market access strategies, developing economic and clinical value propositions and aligning stakeholders for the pharmaceutical industry worldwide.

Metal pipe with empty flange covering the end. A PVC pipe with metal joins and flanges with bolts.

Opinion

Evolving Market Pressures Force Biopharma Companies to Cut Assets Early

From a higher bar for regulatory clearance to pricing limitations, drug development is more expensive than ever. This has led firms to make tough pipeline decisions early in the development process. The result may be costly for all of us.

May 21, 2025

5 min read

Michael N. Abrams